Back to top
Cilastatin for system suitability 1
Cilastatin for system suitability 1

Cilastatin for system suitability 1

MOQ : 1 , , Kilograms

Cilastatin for system suitability 1 Specification

  • Usage
  • Cilastatin helps imipenem work more effectively by preventing the breakdown of the antibiotic in the kidneys. Imipenem and cilastatin is a combination medicine used to treat severe infections of the lower respiratory tract, skin, stomach, or female reproductive organs.
  • Purity
  • 96%
  • Melting Point
  • 158-161°C
  • Molecular Weight
  • 358.5 Grams (g)
  • Molecular Formula
  • C16H26N2O5S
 

Cilastatin for system suitability 1 Trade Information

  • Minimum Order Quantity
  • 1 , , Kilograms
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 500 Kilograms Per Month
  • Delivery Time
  • 2-8 Week
  • Sample Available
  • Yes
  • Sample Policy
  • Sample costs shipping and taxes has to be paid by the buyer
  • Main Export Market(s)
  • Australia, Central America, Africa, Middle East, South America, Western Europe, Asia, Eastern Europe, North America
  • Main Domestic Market
  • Meghalaya
 

About Cilastatin for system suitability 1



Cilastatin for System Suitability 1 is a high-purity compound with a molecular formula of C16H26N2O5S and a molecular weight of 358.5 g/mol. This product has a purity level of 96% and features a melting point of 158-161C, ensuring reliable quality and stability. Cilastatin enhances the efficacy of imipenem by preventing its degradation in the kidneys, which allows the antibiotic to work more effectively. This combination medicine targets severe infections, including lower respiratory tract, skin, stomach, and female reproductive system infections, making it essential for clinical research and pharmaceutical applications. Specially designed for system suitability testing, this product supports precise and consistent results.

FAQs of Cilastatin for system suitability 1:


Q: What is the role of Cilastatin in combination therapy?

A: Cilastatin prevents the breakdown of imipenem in the kidneys, enhancing the antibiotics efficacy in treating severe infections.

Q: What is the purity of Cilastatin for System Suitability 1?

A: Its purity level is 96%.

Q: What infections does this compound target?

A: It is used in combination therapies for severe infections of the lower respiratory tract, skin, stomach, and female reproductive organs.

Q: What are its key physical properties?

A: Cilastatin has a molecular weight of 358.5 g/mol and a melting point range of 158-161C.

Q: What industries commonly use this product?

A: It is primarily used in pharmaceutical research and clinical applications.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Analytical Grade Chemicals Category

2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate

2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate

Appearance : White to offwhite crystalline powder

Molecular Weight : 253.22 g/mol

Usage : Primarily utilized in the manufacture of nucleosidebased pharmaceutical compounds

Purity : ≥ 98%

EPA Phthalate Esters Mix

EPA Phthalate Esters Mix

Appearance : Clear to slightly yellow liquid

Molecular Weight : 390.56 g/mol *(generalized as mix)

Usage : Utilized as internal standards or for analytical calibration in laboratory settings

Purity : > 95%

Iron Ore, Labrador

Iron Ore, Labrador

Appearance : Reddishbrown (hematite) black (magnetite)

Molecular Weight : Varies (Fe2O3: ~159.69 g/mol Fe3O4: ~231.55 g/mol) Grams (g)

Usage : Used in blast furnaces sintering plants and as a primary source of metallic iron

Purity : Varies depending on processing (can exceed 65% Fe for highgrade ore)

Cytarabine

Cytarabine

Price 100 INR

Minimum Order Quantity : 1 Kilograms

Appearance : Colorless crystals

Molecular Weight : 243.217 Grams (g)

Usage : Cytarabine Injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia of adults and pediatric patients. It has also been found useful in the treatment of acute nonlymphocytic leukemia and the blast phase of chronic myelocytic leukemia.